Literature DB >> 20363302

Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect.

Yasuhiro Miyako1, Nawel Khalef, Katsumi Matsuzaki, Rodolfo Pinal.   

Abstract

Drug solubilization is an important aspect of drug development. We investigate the relationship between solute hydrophobicity on the solubilization properties of water-cosolvent mixtures. The solubilization in water-cosolvent mixtures of seven chemically unrelated drugs was determined. The set of solutes included hydrocortisone, sulfanilamide, acetophenetidine, benzocaine, indomethacin, thymol and ibuprofen. Two sets of water-cosolvent mixtures were used in the study. A group of polar cosolvents consisting of three aliphatic alcohols, and a group of the less polar cosolvents NMP, tetraglycol and labrasol. The hydrophobicity of the drug has a direct impact on the solubilization obtained in the water-cosolvent mixtures. However, the role of hydrophobicity is different in the case of the polar cosolvents compared with the less polar ones. In polar cosolvents, the solubilization behavior is typical of polarity match, where the collective trend of solubility enhancement decreases as the activity coefficient of the solute in the solvent mixture increases. The result is a linear profile comprising the combined data of all solutes and all solvents. On the other hand, while the less polar cosolvents exhibit greater positive deviations from the log-linear cosolvency model, the collective solubility enhancement in these systems exhibits no readily discernible pattern. However, by taking into account the hydrophobicity of the solutes, a systematic effect becomes clearly apparent. In this case, the hydrophobicity of the solute demarcates its region in the solubilization profile. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363302     DOI: 10.1016/j.ijpharm.2010.03.059

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

Review 1.  Preclinical formulations: insight, strategies, and practical considerations.

Authors:  Sanket M Shah; Ankitkumar S Jain; Ritu Kaushik; Mangal S Nagarsenker; Maneesh J Nerurkar
Journal:  AAPS PharmSciTech       Date:  2014-06-12       Impact factor: 3.246

2.  Development and Characterization of Eudragit® EPO-Based Solid Dispersion of Rosuvastatin Calcium to Foresee the Impact on Solubility, Dissolution and Antihyperlipidemic Activity.

Authors:  Sana Inam; Muhammad Irfan; Noor Ul Ain Lali; Haroon Khalid Syed; Sajid Asghar; Ikram Ullah Khan; Salah-Ud-Din Khan; Muhammad Shahid Iqbal; Imran Zaheer; Ahmed Khames; Heba A Abou-Taleb; Mohammad A S Abourehab
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-18

3.  Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.

Authors:  Sanyog Jain; Venkata Appa Reddy; Sumit Arora; Kamlesh Patel
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

4.  Solubility Study of Acetylsalicylic Acid in Ethanol + Water Mixtures: Measurement, Mathematical Modeling, and Stability Discussion.

Authors:  Ali Nokhodchi; Taravat Ghafourian; Nour Nashed; Kofi Asare-Addo; Elmira Behboudi; Yasaman Sefid-Sefidehkhan; Aynaz Zarghampour; Elaheh Rahimpour; Abolghasem Jouyban
Journal:  AAPS PharmSciTech       Date:  2021-12-28       Impact factor: 3.246

5.  Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.

Authors:  Jin Qiao; Danyang Ji; Shilin Sun; Guangyuan Zhang; Xin Liu; Bingxue Sun; Qingxiang Guan
Journal:  Pharmaceutics       Date:  2018-09-05       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.